VALUATION
Given the complexities of the life science market, valuations can be a highly cumbersome and speculative exercise. Valuating an emerging life science company is not a simple task of building a financial model and adjusting several inputs. Scientia focuses on both emerging companies and global players giving us the unique ability to include technology assessment validation, commercialization strategy, product positioning and market sizing in a valuation exercise. This expanded valuation process provides both the executive management and the board of directors the breadth and depth of understanding necessary to make critical decisions about the future of the emerging company.Scientia is constantly reviewing private acquisition terms and public company valuations. Our developing databases track both private and public companies, providing us with a plethora of statistics. Scientia provides independent valuations, taking into account both technology assessment and market expansion based on deep technical understanding and broad trends.
To find out more about Scientia’s work in this capability area, please contact us.
Wound Care Market Strategic Review
The wound care market represents an extremely diverse group of products and therapies, ranging from biological growth factors to wound therapy surfaces such as advanced hospital beds and chairs. For the most part, the wound care market has matured, however, there still remain a variety of high-growth, specialized markets that present good opportunites for investment. This presentation outlines the key drivers and trends of the overall wound care market while also providing insight into emerging trends and technologies that are being rapidly advanced by the industry’s increasing understanding and application of biological processes.
The wound care market represents an extremely diverse group of products and therapies, ranging from biological growth factors to wound therapy surfaces such as advanced hospital beds and chairs. For the most part, the wound care market has matured, however, there still remain a variety of high-growth, specialized markets that present good opportunites for investment. This presentation outlines the key drivers and trends of the overall wound care market while also providing insight into emerging trends and technologies that are being rapidly advanced by the industry’s increasing understanding and application of biological processes.
